Sapporo Clinical Laboratory Center, Inc. (9776) AI Stock Analysis

• Market Cap: ¥3.76B
• Dividend Yield: 2.03%
• Average Volume (3M): 2.08K
• Price to Earnings (P/E): 7.6
• Beta (1Y): 0.27
• Revenue Growth: 2.80%
• EPS Growth: 34.63%
• Country: JP
• Employees: 871
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Diagnostics & Research
• EPS (TTM): 65.08
• Shares Outstanding: 4,216,000
• 10 Day Avg. Volume: 600
• 30 Day Avg. Volume: 2,076
• PEG Ratio: 0.22
• Price to Book (P/B): 0.27
• Price to Sales (P/S): 0.15
• P/FCF Ratio: -6.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 68 Neutral
• Price Target: ¥2,127.00 ▲(8.24% Upside)

The overall stock score is driven by strong financial performance and attractive valuation metrics, suggesting a solid investment potential. However, technical indicators highlight a risk of short-term price correction due to overbought conditions. Investors should consider the balance between long-term growth prospects and potential short-term volatility.

Positive Factors

Revenue Growth

Sustained revenue growth indicates strong demand for the company's services, enhancing its market position and supporting long-term financial stability.

Operational Efficiency

Improved margins reflect effective cost management and operational prowess, which can lead to enhanced profitability and competitive advantage over time.

Balance Sheet Health

A robust balance sheet with prudent leverage ensures financial stability and flexibility, enabling the company to invest in growth opportunities and weather economic fluctuations.

Negative Factors

Free Cash Flow Volatility

Volatile free cash flow due to high capital expenditures can strain financial resources, potentially limiting the company's ability to invest in strategic initiatives or respond to market changes.

Net Profit Margin Fluctuation

Inconsistent net profit margins can indicate underlying cost pressures or inefficiencies, which may affect long-term profitability and shareholder returns.

Capital Expenditure Impact

High capital expenditures without corresponding cash flow improvements can impede financial flexibility, necessitating strategic adjustments to ensure sustainable growth.

Sapporo Clinical Laboratory Center, Inc. Business Overview & Revenue Model

Company Description

Sapporo Clinical Laboratory Center, Inc. (9776) is a leading provider of clinical laboratory services in Japan, specializing in a wide range of diagnostic testing and health monitoring solutions. The company operates in the healthcare sector, focusing on delivering accurate and timely laboratory results to hospitals, clinics, and other healthcare facilities. Its core services include blood testing, microbiology, pathology, and genetic testing, catering to both routine and specialized diagnostic needs.

How the Company Makes Money

The company generates revenue primarily through its extensive portfolio of laboratory testing services, billing healthcare providers and patients for tests performed. Key revenue streams include fees for individual tests, subscription models for regular health monitoring services, and contracts with hospitals and clinics for routine testing services. Additionally, Sapporo Clinical Laboratory Center may engage in partnerships with pharmaceutical companies for clinical trials, which can provide supplementary income. The company also benefits from government and insurance reimbursements for eligible laboratory services, contributing significantly to its earnings.

Sapporo Clinical Laboratory Center, Inc. Financial Statement Overview

Summary

Sapporo Clinical Laboratory Center, Inc. shows strong financial performance with consistent revenue growth and operational efficiency. The balance sheet is robust with a favorable debt-to-equity ratio. However, cash flow management needs improvement due to high capital expenditures affecting free cash flow.

Income Statement

Sapporo Clinical Laboratory Center, Inc. has demonstrated consistent revenue growth over the years, with a notable increase in EBIT and EBITDA margins, indicating solid operational efficiency. However, the net profit margin has fluctuated, reflecting some challenges in cost management or external factors impacting net income.

Balance Sheet

The company maintains a strong equity position with a favorable debt-to-equity ratio, indicating prudent financial leverage. The equity ratio is robust, showcasing stability and a solid asset base. Return on Equity has been stable, suggesting effective use of shareholder funds.

Cash Flow

Operating cash flows remain positive, yet there is volatility in free cash flow due to high capital expenditures. The company has shown resilience in generating cash flow from operations, but consistent negative free cash flow suggests the need for careful capital management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	20.20B	20.13B	19.68B	20.13B	19.11B	17.50B
Gross Profit	6.17B	6.14B	5.90B	6.30B	6.32B	5.73B
EBITDA	1.29B	1.27B	1.14B	1.49B	2.06B	1.45B
Net Income	455.83M	464.18M	380.16M	568.62M	1.04B	793.69M
Balance Sheet
Total Assets	16.77B	16.45B	16.68B	16.52B	16.15B	14.51B
Cash, Cash Equivalents and Short-Term Investments	3.11B	2.94B	3.98B	3.66B	2.99B	2.36B
Total Debt	2.03B	1.93B	2.20B	2.43B	2.58B	2.10B
Total Liabilities	5.38B	5.06B	5.50B	5.64B	5.81B	5.24B
Stockholders Equity	11.15B	11.15B	10.94B	10.59B	10.11B	9.27B
Cash Flow
Free Cash Flow	0.00	-491.26M	629.92M	604.44M	625.26M	-2.32B
Operating Cash Flow	0.00	730.91M	1.08B	1.43B	1.57B	837.59M
Investing Cash Flow	0.00	-1.24B	-395.47M	-409.03M	-830.96M	-3.15B
Financing Cash Flow	0.00	-525.74M	-369.96M	-347.89M	-112.74M	1.94B

Sapporo Clinical Laboratory Center, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1965.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9776, the sentiment is Positive. The current price of 1965 is above the 20-day moving average (MA) of 1589.60, above the 50-day MA of 1319.56, and above the 200-day MA of 1086.71, indicating a bullish trend. The MACD of 221.57 indicates Negative momentum. The RSI at 91.80 is Negative, neither overbought nor oversold. The STOCH value of 41.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9776.

Sapporo Clinical Laboratory Center, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4694	74 Outperform	€135.37B	22.00	5.59%	3.17%	5.90%	16.30%
4671	73 Outperform	¥25.02B	13.21	―	5.00%	1.23%	9.96%
2395	69 Neutral	¥72.61B	15.60	―	3.34%	28.06%	19.48%
9776	68 Neutral	¥3.76B	7.57	―	2.03%	2.80%	34.63%
4544	62 Neutral	¥208.38B	54.76	2.65%	3.42%	2.93%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
2385	43 Neutral	¥6.04B	37.00	―	2.16%	-10.24%	―